Molecular mimicry and antigen-specific T cell responses in multiple sclerosis and chronic CNS Lyme disease.

作者: Roland Martin , Bruno Gran , Yingdong Zhao , Silva Markovic-Plese , Bibiana Bielekova

DOI: 10.1006/JAUT.2000.0501

关键词:

摘要: The concept of molecular mimicry provides and elegant framework as to how cross-reactivity between antigens from a foreign agent with self proteins may trigger autoimmune diseases. While it was previously thought that sequence structural homology or the sharing T cell receptor (TCR) MHC-binding motifs are required for occur, we have shown even completely unrelated peptide sequences lead cross-recognition by cells. use synthetic combinatorial libraries in positional scanning format (PS-SCL) together novel biometric prediction approaches has allowed us describe recognition profiles individual autoreactive clones (TCC) unprecedented accuracy. Through studies myelin-specific TCC well nervous system patients suffering chronic central (CNS) Lyme disease become clear at least some cells more degenerate than anticipated. These data will not only help redefine what constitutes specific recognition, but also allow study detail biological role mimicry. A recent clinical trial an altered ligand (APL) one candidate myelin basic protein (MBP) epitopes MS (amino acids 83-99) such modified MBP therapeutic efficacy, bears potential exacerbate disease. Thus, provide firm evidence principles their pathogenetic significance relevant MS.

参考文章(49)
Magdalena Plebanski, Edwin A.M. Lee, Carolyn M. Hannan, Katie L. Flanagan, Sarah C. Gilbert, Michael B. Gravenor, Adrian V.S. Hill, Altered peptide ligands narrow the repertoire of cellular immune responses by interfering with T-cell priming Nature Medicine. ,vol. 5, pp. 565- 571 ,(1999) , 10.1038/8444
Henry F. McFarland, Bruno Gran, Paul Conlon, Richard Houghten, Clemencia Pinilla, Bernhard Hemmer, Roland Martin, Marco Vergelli, Nick Ling, Cutting Edge: Predictable TCR Antigen Recognition Based on Peptide Scans Leads to the Identification of Agonist Ligands with No Sequence Homology Journal of Immunology. ,vol. 160, pp. 3631- 3636 ,(1998)
John E. Coligan, Henry McFarland, Matthias Kalbus, Paul Conlon, Bernhard Hemmer, Roland Martin, Anne B. Vogt, Marco Vergelli, Nick Ling, Modifications of peptide ligands enhancing T cell responsiveness imply large numbers of stimulatory ligands for autoreactive T cells. Journal of Immunology. ,vol. 158, pp. 3746- 3752 ,(1997)
Michael B. A. Oldstone, Abner Louis Notkins, Concepts in viral pathogenesis ,(1984)
Bibiana Bielekova, Bonnie Goodwin, Nancy Richert, Irene Cortese, Takayuki Kondo, Ghazaleh Afshar, Bruno Gran, Joan Eaton, Jack Antel, Joseph A. Frank, Henry F. McFarland, Roland Martin, Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand. Nature Medicine. ,vol. 6, pp. 1167- 1175 ,(2000) , 10.1038/80516
Lindsay B Nicholson, Judith M Greer, Raymond A Sobel, Marjorie B Lees, Vijay K Kuchroo, None, An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis Immunity. ,vol. 3, pp. 397- 405 ,(1995) , 10.1016/1074-7613(95)90169-8
Paul D. Crowe, Yufen Qin, Paul J. Conlon, Jack P. Antel, NBI-5788, an altered MBP83-99 peptide, induces a T-helper 2-like immune response in multiple sclerosis patients. Annals of Neurology. ,vol. 48, pp. 758- 765 ,(2000) , 10.1002/1531-8249(200011)48:5<758::AID-ANA9>3.0.CO;2-2
Stefan Brocke, Koenraad Gijbels, Mark Allegretta, Iris Ferber, Christopher Piercy, Thomas Blankensteini, Roland Martin, Ursula Utz, Nathan Karin, Dennis Mitchell, Timo Veromaa, Ari Waisman, Amitabh Gaur, Paul Conlon, Nicholas Ling, Paul J. Fairchild, David C. Wraith, Anne O'Garra, C. Garrison Fathman, Lawrence Steinman, Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein Nature. ,vol. 379, pp. 343- 346 ,(1996) , 10.1038/379343A0
W SIBLEY, CLINICAL VIRAL INFECTIONS AND MULTIPLE SCLEROSIS The Lancet. ,vol. 325, pp. 1313- 1315 ,(1985) , 10.1016/S0140-6736(85)92801-6